Earlier this month, the White House announced a sweeping package of tariffs on European imports. The administration also indicated that “major” tariffs on pharmaceutical products could be next.

Using economic pressure to hold foreign governments accountable is a tried and tested strategy. And in some cases, it’s already proving effective for President Trump.

But targeting European medicines is the wrong move. It doesn’t punish leaders across the Atlantic — it punishes Americans by driving up federal healthcare spending, drug costs, and drug shortages. And while the United States pays more for fewer options, China will seize the moment and accelerate its push to dominate the global pharmaceutical market.

Read more at Newsmax© 2025 Newsmax. All rights reserved.